Los puntos clave no están disponibles para este artículo en este momento.
The NF-κB pathway is a critical regulator of immune responses and is often dysregulated in cancer. Two NF-κB pathways have been described to mediate these responses, the canonical and the noncanonical. While understudied compared to the canonical NF-κB pathway, noncanonical NF-κB and its components have been shown to have effects, usually protumorigenic, in many different cancer types. Here, we review noncanonical NF-κB pathways and discuss its important roles in promoting cancer. We also discuss alternative NF-κB-independent functions of some the components of noncanonical NF-κB signaling. Finally, we discuss important crosstalk between canonical and noncanonical signaling, which blurs the two pathways, indicating that understanding the full picture of NF-κB regulation is critical to deciphering how this broad pathway promotes oncogenesis.
Building similarity graph...
Analyzing shared references across papers
Loading...
Matthew Tegowski
Duke University
Albert S. Baldwin
University of North Carolina at Chapel Hill
Biomedicines
University of North Carolina at Chapel Hill
Building similarity graph...
Analyzing shared references across papers
Loading...
Tegowski et al. (Tue,) studied this question.
synapsesocial.com/papers/6a1dc4ece30813deec34cb64 — DOI: https://doi.org/10.3390/biomedicines6020066
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: